Regencell Bioscience Holdings (RGC) Balance Sheet: Assets & Liabilities

Regencell Bioscience Holdings Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Regencell Bioscience Holdings Limited (RGC) - Annual data in billions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Dec 2017	Dec 2016
Current Assets
Cash and Cash Equivalents	0.01	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.23	0.25
Short-Term Investments	-	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	0.01	0.00	0.01	0.01	0.02	0.00	0.00	0.00	0.23	0.25
Accounts Receivable	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.16
Inventory	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.02
Other Current Assets	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.02
Total Current Assets	0.01	0.00	0.01	0.01	0.02	0.00	0.00	0.00	0.46	0.45
Non-Current Assets
Property, Plant & Equipment (Net)	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.51	1.39
Goodwill	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.35	0.33
Intangible Assets	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.05
Other Non-Current Assets	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.38
Total Non-Current Assets	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.38	2.20
Total Assets	0.01	0.01	0.01	0.01	0.02	0.00	0.00	0.00	2.84	2.65
Current Liabilities
Accounts Payable	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.19
Short-Term Debt	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.03
Accrued Liabilities	-	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Deferred Revenue	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.19
Other Current Liabilities	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.10
Total Current Liabilities	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.56	0.51
Non-Current Liabilities
Long-Term Debt	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.34	2.20
Other Non-Current Liabilities	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.39	0.37
Total Non-Current Liabilities	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.14	2.97
Total Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.70	3.48
Stockholders' Equity
Common Stock	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-	-0.03	-0.02	-0.02	-0.01	0.00	0.00	0.00	0.07	0.10
Accumulated Other Comprehensive Income	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-2.24	-2.15
Additional Paid-in Capital	-	0.03	0.03	0.03	0.03	0.00	0.00	0.00	1.31	1.21
Minority Interest	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	-	-	0.49	0.49	0.49	0.48	-	-	-	-
Total Stockholders' Equity	0.01	0.00	0.01	0.01	0.02	0.00	0.00	0.00	-0.86	-0.84
Total Liabilities & Equity	-	0.01	0.01	0.01	0.02	0.00	0.00	0.00	2.84	2.65

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Regencell Bioscience Holdings Balance Sheet

What are Regencell Bioscience Holdings's total assets?

Regencell Bioscience Holdings reported total assets of $14.73M as of Jun 30, 2026, up 155.9% from $5.76M a year earlier. Total liabilities were $1.38M.

What is Regencell Bioscience Holdings's shareholders' equity?

Regencell Bioscience Holdings's shareholders' equity was $13.35M as of Jun 30, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition